SarahPatriciaPsutkaMDMSc

PubMed

• Phase 1/2 Randomized Clinical Trial of In-clinic acupuncture Prior to Bacillus Calmette-Guérin in Patients with High-risk Non-muscle-invasive Bladder Cancer.
  Susan Veleber, Jonathan Siman, Sarah K Holt, Samia Jannat, Zachary Annen, Heather Greenlee, Sarah P Psutka, Jonathan L Wright, Daniel W Lin, John L Gore, George R Schade> ;European Urology Oncology. 2024 Apr 22
• Linear Muscle Segmentation for Metastatic Renal Cell Carcinoma: Changes in Clinic-Friendly Estimation Predict Survival Following Cytoreductive Nephrectomy.
  Nicaise, E., Schmeusser, B., Ali, A., Midenberg, E., Palacios, A., Hartsoe, B., Kearns, E., Ambadi, S., Patil, D., Joshi, S., Narayan, V., Psutka, S., Nazha, B., Brown...> ;Clinical Genitourinary Cancer. 2024 Feb 16
• Prehabilitation: A multidimensional adjunct to comprehensive personalized oncologic care. But, can we make it pragmatic?
  Psutka, S.> ;European Urology Focus. 2024 Jan 1
• 1 citations
  Immune Checkpoint Inhibitor Therapy Before Nephrectomy for Locally Advanced and Metastatic Renal Cell Carcinoma: A Review.
  Ulka Vaishampayan, Ming Yin, Sarah P Psutka, Hooman Djaladat, Alireza Ghoreifi> ;JAMA Oncology. 2024 Feb 1
• Standardization of the evaluation and surveillance of patients with BCG unresponsive high grade non-muscle invasive bladder cancer clinical trials.
  Lee, B., Smith, A., Lotan, Y., Agarwal, P., Black, P., Dickstein, R., Kamat, A., Narayan, V., Porten, S., Psutka, S., Svatek, R., Williams, S., Woldu, S.> ;Urologic Oncology. 2024 Feb 1
• Surgically Feasible? Yes. But Is It the Right Option? It Depends.
  Daniel Carson, Sarah Psutka> ;International Journal of Radiation Oncology, Biology, Physics. 2023 Dec 1
• Emerging Role of Mobile Applications and Wearable Devices for Prehabilitation in Urologic Oncology.
  Hanna Hunter, Nicole Bennington-McKay, Jessica Sher, Sarah P Psutka, Cindy Lin> ;European Urology Focus. 2024 Jan 1
• Bladder cancer oligometastases - definition and treatment.
  Laura S Mertens, Sarah P Psutka, Maria Carmen Mir> ;Nature Reviews. Urology. 2023 Dec 1
• Creatinine to Cystatin-C Ratio in Renal Cell Carcinoma: A Clinically Pragmatic Prognostic Factor and Sarcopenia Biomarker.
  Benjamin N Schmeusser, Adil A Ali, Dattatraya H Patil, Eric Midenberg, Talia Helman, Manuel Armas-Phan, Reza Nabavizadeh, Shreyas S Joshi, Vikram M Narayan, Mehmet A B...> ;The Oncologist. 2023 Dec 11
• The Judicious Use of Stereotactic Ablative Radiotherapy in the Primary Management of Localized Renal Cell Carcinoma.
  Andrew B Barbour, Simon Kirste, Anca-Liga Grosu, Shankar Siva, Alexander V Louie, Hiroshi Onishi, Anand Swaminath, Bin S Teh, Sarah P Psutka, Emily S Weg, Jonathan J C...> ;Cancers. 2023 Jul 19
• 3 citations
  Prognostic Significance of Grade Discrepancy Between Primary Tumor and Venous Thrombus in Nonmetastatic Clear-cell Renal Cell Carcinoma: Analysis of the REMEMBER Regis...
  Zhenjie Wu, Hui Chen, Qi Chen, Silun Ge, Nengwang Yu, Riccardo Campi, Juan Gómez Rivas, Riccardo Autorino, Morgan Rouprêt, Sarah P Psutka, Reza Mehrazin, Francesco Por...> ;European Urology Oncology. 2024 Feb 1
• 1 citations
  Engaging disparities in prostate cancer: Piloting an interactive, virtual workshop to educate providers on shared decision-making for underserved populations.
  Neil A Mistry, Jamila Sweis, Bernice Ofori, June M McKoy, Aisha Langford, Sarah P Psutka, Elizabeth Perazza, Jay D Raman, Adam B Murphy> ;Urologic Oncology. 2023 Oct 1
• Adding Stereotactic Radiation to the Multidisciplinary Armamentarium for Localized Renal Cell Carcinoma: Ready for Primetime? : An Editorial Regarding a Recent 5-Year ...
  Elizabeth L Koehne, Sarah P Psutka> ;Annals of Surgical Oncology. 2023 Nov 1
• 2 citations
  Surgical Management of Localized Disease and Small Renal Masses.
  Daniel S Carson, Tova Weiss, Lisa Xinyuan Zhang, Sarah P Psutka> ;Hematology/oncology Clinics of North America. 2023 Oct 1
• 32 citations
  Diagnosis and Management of Non-Metastatic Upper Tract Urothelial Carcinoma: AUA/SUO Guideline.
  Jonathan A Coleman, Peter E Clark, Brooke R Bixler, David I Buckley, Sam S Chang, Roger Chou, Jean Hoffman-Censits, Girish S Kulkarni, Surena F Matin, Phillip M Pieror...> ;The Journal of Urology. 2023 Jun 1
• 1 citations
  Low Skeletal Muscle as a Risk Factor for Worse Survival in Nonmetastatic Renal Cell Carcinoma with Venous Tumor Thrombus.
  Benjamin N Schmeusser, Eric Midenberg, Arnold R Palacios, Adil A Ali, Dattatraya H Patil, Michelle Higgins, Reza Nabavizadeh, Benjamin Croll, Milton Williams, John She...> ;Clinical Genitourinary Cancer. 2023 Aug 1
• 2 citations
  Imaging Techniques to Determine Degree of Sarcopenia and Systemic Inflammation in Advanced Renal Cell Carcinoma.
  Benjamin N Schmeusser, Adil A Ali, Florian J Fintelmann, Jose M Garcia, Grant R Williams, Viraj A Master, Sarah P Psutka> ;Current Urology Reports. 2023 Jul 1
• 1 citations
  Sarcomatoid Urothelial Carcinoma Is Associated With Limited Response to Neoadjuvant Chemotherapy and Poor Oncologic Outcomes After Radical Cystectomy.
  Rishi R Sekar, Leonidas N Diamantopoulos, Dimitra R Bakaloudi, Ali R Khaki, Petros Grivas, Brian R Winters, Funda Vakar-Lopez, Maria S Tretiakova, Sarah P Psutka, Sara...> ;Clinical Genitourinary Cancer. 2023 Aug 1
• 2 citations
  Patients' Perceptions Regarding the Relevance of Items Contained in the Functional Assessment of Cancer Therapy Kidney Symptom Index-19.
  Cristiane Decat Bergerot, Jasnoor Malhotra, Paulo Bergerot, Errol J Philip, Daniela V Castro, JoAnn Hsu, Augusto Cesar de Andrade Mota, Andressa Cardoso de Azeredo, Jo...> ;The Oncologist. 2023 Jun 2
• 5 citations
  Robot-assisted retroperitoneal lymph node dissection: a systematic review of perioperative outcomes.
  Harshit Garg, Ahmed M Mansour, Sarah P Psutka, Simon P Kim, James Porter, Christine S Gaspard, Furkan Dursun, Deepak K Pruthi, Hanzhang Wang, Dharam Kaushik> ;BJU International. 2023 Jul 1
• 4 citations
  Association Between Antibiotic Prophylaxis Before Cystectomy or Stent Removal and Infection Complications: A Systematic Review.
  Luca Antonelli, Kirby Sebro, Abdelilah Lahmar, Peter C Black, Saum Ghodoussipour, Jill M Hamilton-Reeves, Jay Shah, Jensen Bente Thoft, Seth Paul Lerner, Carlos Lloren...> ;European Urology Focus. 2023 Jul 1
• Salvage lenvatinib/everolimus combination therapy after immune checkpoint inhibitor and VEGFR tyrosine kinase inhibitor for metastatic renal cell carcinoma.
  Christopher Kwok, Adam Khorasanchi, Sarah P Psutka, Megan Hinkley, Shawn Dason, Debasish Sundi, Yuanquan Yang, Yajing Yang, Claire Verschraegen, Evan E Gross, Delaney ...> ;Frontiers in Oncology. 2023 Jan 1
• 8 citations
  A multicenter study assessing survival in patients with metastatic renal cell carcinoma receiving immune checkpoint inhibitor therapy with and without cytoreductive ne...
  Evan E Gross, Mingjia Li, Ming Yin, Delaney Orcutt, Duncan Hussey, Elliot Trott, Sarah K Holt, Erin R Dwyer, Joel Kramer, Kaylee Oliva, John L Gore, George R Schade, D...> ;Urologic Oncology. 2023 Jan 1
• Effects of acupuncture to decrease adverse events in patients with high-risk non-muscle invasive bladder cancer receiving induction intravesical BCG therapy: Study pro...
  Sarah P Psutka, Susan Veleber, Jonathan Siman, Samia Jannat, Sarah Holt, Jonathan L Wright, Heather Greenlee> ;Contemporary Clinical Trials Communications. 2022 Dec 1
• 2 citations
  Data regarding covariates significantly associated with sarcopenia and varying albumin statuses in patients with renal cell carcinoma.
  Benjamin N Schmeusser, Dattatraya H Patil, Eric Midenberg, Michelle I Higgins, Dylan J Martini, Sean Steele, Milton Williams, Reza Nabavizadeh, Sarah P Psutka, Kenneth...> ;Data in Brief. 2022 Dec 1
• Join now to see all

Lectures

• Cytoreductive Nephrectomy Still an Important Tool in Management of Metastatic Renal Cell Carcinoma 
  ASCO Annual Meeting 2019 - Chicago, IL - 6/2/2019